Clinic Bills
J&J medtech revenue growth stalls amid Abiomed setback
Oct 14, 2026
Cancer Costs, Exposed

Zenflow secures $52 million in funding for its urology device to treat benign prostatic hyperplasia.










Johnson & Johnson’s medtech revenue growth stalls at 2.5% in Q3, missing projections amid Abiomed’s underperformance after a $16.6B acquisition.





Surrogacy may put a marriage to the test, about one of life's biggest challenges, with...
A Black woman's pregnancy loss exposes critical systemic healthcare failures in timely uterine rupture intervention...
Migraine risk may be linked to weather factors like air pollution and temperature, according to...



